In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Smith & Nephew withdraw 185 BHR (Birmingham Hip Resurfacing) implants:

This article was originally published in Clinica

Executive Summary

Smith & Nephew has recalled 185 of its Birmingham Hip Resurfacing system after discovering that the implants had been incorrectly packaged by the subcontractor. The mistake led to different sized acetabular cups being mixed together. S&N said the error was limited to a small number of batches and that several implants have already been recovered in their packaging. The company added that it has warned, or is in the process of warning, all hospitals that have received the implants and are -working closely" with surgeons and patients on the appropriate corrective action. The UK and US regulatory authorities have also been notified about the recall.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel